Microvascular Therapeutics selected as a Participant in the 2024 Landmark Venture Forum
Microvascular Therapeutics selected as a Participant in the 2024 Landmark Venture Forum [Tucson, AZ] – Microvascular Therapeutics Inc....
top of page
MVT: In the News
Search
- Feb 8
Microvascular Therapeutics welcomes Thom Tulip as Chief Business Officer
[Tucson, Arizona] – [2/05/2024] – Microvascular Therapeutics Inc. (MVT), a clinical-stage biotech company at the forefront of developing...
- Dec 12, 2023
Microvascular Therapeutics Selected as a Participant in the 2023 H7 BioCapital Accelerator Program
Microvascular Therapeutics (MVT), a clinical stage biopharma pioneering the potential of ultrasound in diagnostics and theranostics, has...
- Dec 12, 2023
Breakthrough Study by Microvascular Therapeutics Reveals Fibrin-Targeted Phase Shift Microbubbles as
Microvascular Therapeutics, a trailblazing healthcare research and development company, announces a groundbreaking study on the treatment...
bottom of page